M&A - Nowtransit Inc

Form Type: 10-K

Filing Date: 2025-03-13

Corporate Action: Merger

Type: New

Accession Number: 000118518525000176

Filing Summary: Nowtransit Inc. was incorporated in Nevada on July 8, 2019, and underwent a reverse merger with Best 365 Labs Inc. on March 10, 2023. This transaction involved issuing 34,371,100 shares of Nowtransit to the shareholders of Best, representing approximately 85.39% of the combined company. Post-merger, Nowtransit shifted its focus to selling clinically-tested health products to combat bacteria and viruses. The company has faced challenges such as minimal revenue, limited assets, and substantial losses since its inception. The stock experiences volatility and operates on the OTC Pink Market. As of December 31, 2024, 43,916,221 shares are outstanding with a limited trading market. The report includes risk factors related to investment and operational challenges, emphasizing the need for future capital and potential impacts on stock performance due to regulations and market conditions. No cash dividends have been declared, and the company currently does not have equity compensation plans.

Document Link: View Document